17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response

Detalhes bibliográficos
Autor(a) principal: Santos, M.
Data de Publicação: 2015
Outros Autores: Gomes, M., Moreno, F., Rocha, A., Lopes, C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.16/1983
Resumo: Neoadjuvant chemoradiation (CRT) followed by curative surgery still remains the standard of care for locally advanced rectal cancer (LARC). The main purpose of this multimodal treatment is to achieve a complete pathological tumor response (ypCR), with better survival. The surgery delay after CRT completion seems to increase tumor response and ypCR rate. Usually, time intervals range from 8 to 12 weeks, but the maximum tumor regression may not be seen in rectal adenocarcinomas until several months after CRT. About this issue, we report a case of a 52-year-old man with LARC treated with neoadjuvant CRT who developed, one month after RT completion, an acute myocardial infarction. The need to increase the interval between CRT and surgery for 17 weeks allowed a curative surgery without morbidity and an unexpected complete tumor response in the resected specimen (given the parameters presented in pelvic magnetic resonance imaging (MRI) performed 11 weeks after radiotherapy completion).
id RCAP_ba95e69f37212e0504aa1465586fed8c
oai_identifier_str oai:repositorio.chporto.pt:10400.16/1983
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological ResponseNeoadjuvant chemoradiation (CRT) followed by curative surgery still remains the standard of care for locally advanced rectal cancer (LARC). The main purpose of this multimodal treatment is to achieve a complete pathological tumor response (ypCR), with better survival. The surgery delay after CRT completion seems to increase tumor response and ypCR rate. Usually, time intervals range from 8 to 12 weeks, but the maximum tumor regression may not be seen in rectal adenocarcinomas until several months after CRT. About this issue, we report a case of a 52-year-old man with LARC treated with neoadjuvant CRT who developed, one month after RT completion, an acute myocardial infarction. The need to increase the interval between CRT and surgery for 17 weeks allowed a curative surgery without morbidity and an unexpected complete tumor response in the resected specimen (given the parameters presented in pelvic magnetic resonance imaging (MRI) performed 11 weeks after radiotherapy completion).Hindawi Publishing CorporationRepositório Científico do Centro Hospitalar Universitário de Santo AntónioSantos, M.Gomes, M.Moreno, F.Rocha, A.Lopes, C.2016-08-01T09:18:32Z20152015-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.16/1983engCase Rep Surg. 2015;2015:8164912090-691910.1155/2015/816491info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-10-20T10:58:32Zoai:repositorio.chporto.pt:10400.16/1983Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:38:17.291064Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response
title 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response
spellingShingle 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response
Santos, M.
title_short 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response
title_full 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response
title_fullStr 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response
title_full_unstemmed 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response
title_sort 17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response
author Santos, M.
author_facet Santos, M.
Gomes, M.
Moreno, F.
Rocha, A.
Lopes, C.
author_role author
author2 Gomes, M.
Moreno, F.
Rocha, A.
Lopes, C.
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Centro Hospitalar Universitário de Santo António
dc.contributor.author.fl_str_mv Santos, M.
Gomes, M.
Moreno, F.
Rocha, A.
Lopes, C.
description Neoadjuvant chemoradiation (CRT) followed by curative surgery still remains the standard of care for locally advanced rectal cancer (LARC). The main purpose of this multimodal treatment is to achieve a complete pathological tumor response (ypCR), with better survival. The surgery delay after CRT completion seems to increase tumor response and ypCR rate. Usually, time intervals range from 8 to 12 weeks, but the maximum tumor regression may not be seen in rectal adenocarcinomas until several months after CRT. About this issue, we report a case of a 52-year-old man with LARC treated with neoadjuvant CRT who developed, one month after RT completion, an acute myocardial infarction. The need to increase the interval between CRT and surgery for 17 weeks allowed a curative surgery without morbidity and an unexpected complete tumor response in the resected specimen (given the parameters presented in pelvic magnetic resonance imaging (MRI) performed 11 weeks after radiotherapy completion).
publishDate 2015
dc.date.none.fl_str_mv 2015
2015-01-01T00:00:00Z
2016-08-01T09:18:32Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.16/1983
url http://hdl.handle.net/10400.16/1983
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Case Rep Surg. 2015;2015:816491
2090-6919
10.1155/2015/816491
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hindawi Publishing Corporation
publisher.none.fl_str_mv Hindawi Publishing Corporation
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133644154994688